Project Management for Drug Developers
CRC Press (Verlag)
978-1-032-12668-5 (ISBN)
Project managers in drug development are the driving force behind the coordination of efforts. This book provides a practical reference for project managers in the pharmaceutical and biotech drug development industry, with the goal of assisting in creating an efficient and effective team structure and environment. The text details the role of project managers at each stage of drug development, the key interfaces that the PM will need to work closely with, and essential tools of the trade including frequently used techniques and methodologies. This book is useful for both entry-level and advanced-level PMs, as well as non-project managers from other functions.
Features
Includes authors' recent experience with improved tactics and technologies/software at various stages of drug development.
Provides the most up-to-date and best practices, techniques, and methodologies in project management.
Details the role of the PM at each stage of drug development, including working with the key interfaces throughout the process.
Diverse audience including nonproject managers in clinical development, clinical operations, regulatory affairs, medical affairs, clinical pharmacology, and biostatistics.
Provides templates and timelines for critical paths from development to commercialization and has potential as a textbook on relevant courses.
Dr. Joseph P. Stalder Joe Stalder, Pharm.D., PMP, is a Senior Director of Project Management at Mirati Therapeutics in San Diego, USA. He received his Bachelor's degree in Pharmacology from the University of California, Santa Barbara, and his Doctor of Pharmacy program at the University of California, San Diego. After receiving his PharmD, he completed a post-doctoral fellowship at Forest Laboratories in New York/ New Jersey, during which he also served as an adjunct professor at St. John's University in Queens, NY. Joe has more than 10 years of project management experience in pharmaceutical development in both large and small companies. His experiences include PM department head, PMO head, and PM Lead on several late-stage development assets in oncology, infectious disease, cardiology, metabolism, and pulmonology.
Part 1: The Role of PM in Drug Development
I. Overview of Drug Development
II. Project Management’s Place in Drug Development and the Various PM Roles in Biopharma
III. Project Teams
IV. The Project Management Office
V. Project Portfolio Management
Part 2: Contemporary Topics in Drug Development
I. Managing Projects with an Agile Mindset
II. Managing International Projects
III. Managing Combination Drug-Device Projects
IV. How Technology Can Assist Project Managers Now and in the Future
V. Assessing, Selecting, and Implementing a Project Management Information System
VI. Creating an Asset Development Plan
VII. Creating a Clinical Development Plan
VIII. Creating a Market Application Submission
Part 3: GRIDALL: A Comprehensive Framework for Managing Projects
I. Introduction to GRIDALL
II. Goals
III. Risks
IV. Issues
V. Decisions
VI. Actions
VII. Lessons Learned
| Erscheinungsdatum | 16.12.2022 |
|---|---|
| Reihe/Serie | Drugs and the Pharmaceutical Sciences |
| Zusatzinfo | 60 Line drawings, color; 3 Halftones, color; 63 Illustrations, color |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Gewicht | 640 g |
| Themenwelt | Medizin / Pharmazie |
| Naturwissenschaften ► Biologie | |
| Naturwissenschaften ► Chemie | |
| ISBN-10 | 1-032-12668-X / 103212668X |
| ISBN-13 | 978-1-032-12668-5 / 9781032126685 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
